Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity
Journal of the American Chemical Society · 21.01.2026 · 148 (2) · 2660-2672
DOI: 10.1021/jacs.5c18904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.12.2025. Verfasst von Jiao Xia Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore 117543, Singapore. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Immunogenic Cell Death, Antineoplastic Agents, Organoplatinum Compounds. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council, University Grants Committee, Ministry of Education - Singapore, National University of Singapore.
Abstract (Originalsprache)
Immunogenic cell death (ICD) inducers are valuable chemotherapeutic agents that elicit protective immune responses against tumors. Although many ICD inducers have emerged in recent years, specific molecular targets directly associated with ICD remain relatively unexplored. Here, two Type II ICD inducers, Pt-NHC and PlatinER (Pt-ER), were validated as bona fide ICD inducers with the ability to establish immunity against colorectal cancer in vivo. Based on Pt-ER, several ICD-inducing photoactivable probes were designed to capture their potential targets. By integrating quantitative proteomics analysis with biochemical assays, we identified PTP1B as a direct target of Pt-ER that engages in ICD. Both Pt-ER and Pt-NHC were shown to directly interact with PTP1B and inhibit its enzymatic activity. The suppression of PTP1B, by either genetic knockdown or pharmacological inhibition, enhanced the immunogenicity of tumor cells by increasing surface-exposed calreticulin and phagocytosis of cancer cells. Bioinformatic analysis also revealed that PTP1B plays a role in tumor progression and immune regulation in colorectal cancer. Therefore, our study first reveals a previously unrecognized role of PTP1B in modulating ICD and highlights its potential therapeutic values in cancer chemoimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore 117543, Singapore.
- Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong, SAR 999077, People's Republic of China.
- NUS Graduate School - Integrative Sciences and Engineering Programme (ISEP), National University of Singapore, 21 Lower Kent Ridge Road, Singapore 119077, Singapore.
ORCID-Profile: Maria V Babak, Wee Han Ang
Förderung
- Research Grants Council, University Grants Committee
- Ministry of Education - Singapore
- National University of Singapore
Zitieren
APA
Zou, J. X., Ivanov-Rostovtsev, P. A., Arakelyan, J., Babak, M. V., & Ang, W. H. (2026). Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity. Journal of the American Chemical Society, 148(2), 2660-2672. https://doi.org/10.1021/jacs.5c18904
Vancouver
Zou JX, Ivanov-Rostovtsev PA, Arakelyan J, Babak MV, Ang WH. Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity. Journal of the American Chemical Society. 2026;148(2):2660-2672. doi:10.1021/jacs.5c18904
BibTeX
@article{Zou2026,
author = {Zou, Jiao Xia and Ivanov-Rostovtsev, Pavel A and Arakelyan, Jemma and Babak, Maria V and Ang, Wee Han},
title = {Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {2},
pages = {2660--2672},
doi = {10.1021/jacs.5c18904}
}
EUVIMED